FISHER + PAYKEL HEALTH.
Research FISHER + PAYKEL HEALTH. (FPLB) on Bullrun: market cap EUR 11.10B, P/E 47.3, dividend yield 1.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerFPLB
- ExchangeF
- CountryNew Zealand
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyEUR
- Market capEUR 11.10B
- P/E47.3
- Dividend yield1.2%
- Financial periodQ1 2025
- RevenueNZD 1.28B
- Net incomeNZD 377.20M
- Free cash flowNZD 445.60M
- Gross margin41.4%
Valuation Snapshot
latest market cap is EUR 11.10B; P/E is 47.3; dividend yield is 1.2%.
Peer valuation comparison
Latest P/E is 47.25x versus a Healthcare sector median of 24.46x (93.2% above).
Latest dividend yield is 1.17% versus a Healthcare sector median of 2.11% (44.5% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-06-17 | EUR 11.10B | 47.3 | 1.4% | 0.26 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.26 EUR, yield 1.2%.
About FISHER + PAYKEL HEALTH.
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. The company provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is FISHER + PAYKEL HEALTH.'s market cap?
FISHER + PAYKEL HEALTH.'s market capitalization is EUR 11.10B.
What is FISHER + PAYKEL HEALTH.'s P/E ratio?
FISHER + PAYKEL HEALTH.'s price-to-earnings (P/E) ratio is 47.3.
Does FISHER + PAYKEL HEALTH. pay a dividend?
FISHER + PAYKEL HEALTH. has a dividend yield of 1.2%.
What does FISHER + PAYKEL HEALTH. do?
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. The company provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. It also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation.